On Friday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) was 2.44% up from the session before settling in for the closing price of $7.39. A 52-week range
On Friday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) opened lower -0.92% from the last session, before settling in for the closing price of $7.60. Price fluctuations
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Tuesday, soared 2.59% from the previous trading day, before settling in for the closing price of $7.73. Within the
On Tuesday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) was -2.57% drop from the session before settling in for the closing price of $7.38. A 52-week range
On Monday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) opened lower -4.34% from the last session, before settling in for the closing price of $7.60. Price fluctuations
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) established initial surge of 1.25% at $7.30, before settling in for the price of $7.21 at the close. Taking a
Witnessing the stock’s movement on the chart, on Thursday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) had a quiet start as it plunged -2.49% to $7.45, before
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) kicked off on Monday, up 5.27% from the previous trading day, before settling in for the closing price of $7.78.
As on Wednesday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) got off with the flyer as it spiked 9.57% to $7.73, before settling in for the price
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Friday, soared 5.24% from the previous trading day, before settling in for the closing price of $8.01. Within the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
